Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and azadirachtin

9,10-dimethyl-1,2-benzanthracene has been researched along with azadirachtin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, GH; Manikandan, P; Nagini, S; Priyadarsini, RV1
Harish Kumar, G; Nagini, S; Vidjaya Letchoumy, P; Vidya Priyadarsini, R; Vinothini, G1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and azadirachtin

ArticleYear
The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis.
    Free radical research, 2009, Volume: 43, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Base Sequence; Cheek; Cricetinae; DNA Damage; DNA Primers; Enzymes; Free Radical Scavengers; In Vitro Techniques; Limonins; Male; Mesocricetus; Mouth Mucosa; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Xenobiotics

2009
The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis.
    Investigational new drugs, 2010, Volume: 28, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Azadirachta; Cell Cycle Proteins; Cell Proliferation; Cricetinae; Disease Models, Animal; Drug Screening Assays, Antitumor; Limonins; Male; Mouth Neoplasms; Random Allocation

2010